SRRK · Scholar Rock Holding Corp
$49.12
-0.26 (-0.52%)
At close · Jul 29
Market Cap
$5.92B
Shares
119.83M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | CEO | $7,991,933 |
| Jing Marantz | Chief Medical Officer | $3,078,300 |
| Mo Qatanani | Head of Research | $2,959,480 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | CEO | $4,111,853 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jay Backstrom | CEO | $7,076,259 |
| Edward H. Myles | CFO | $3,109,887 |
| Greg Carven | Former Chief Scientific Officer | $3,086,971 |
| Nagesh Mahanthappa | CEO | $2,843,861 |
| Junlin Ho | General Counsel | $2,128,356 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stuart A. Kingsley | CEO | $9,615,967 |
| Edward H. Myles | CFO | $5,516,053 |
| Nagesh Mahanthappa | CEO | $5,095,264 |
| Yung H. Chyung M.D | Chief Medical Officer | $3,809,382 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stuart A. Kingsley | CEO | $4,952,846 |
| Nagesh Mahanthappa | CEO | $4,131,091 |
| Edward H. Myles | CFO | $3,116,355 |
| Gregory J. Carven Ph.D | Chief Scientific Officer and former Head of Research | $1,570,631 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Nagesh Mahanthappa | CEO | $2,158,650 |
| Nagesh K. Mahanthappa Ph.D | CEO | $2,158,650 |
| Rhonda M. Chicko | CFO | $1,473,278 |
| Yung H. Chyung | Chief Medical Officer | $1,169,527 |
| Alan J. Buckler | Chief Scientific Officer | $1,093,972 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Nagesh K. Mahanthappa Ph.D | CEO | $3,042,227 |
| Rhonda M. Chicko | CFO | $1,641,828 |
Key facts
CIK
1727196
CUSIP
80706P103
13F (30d)
51 filings
51 filers
Visit website
Investor relations